MONDAY, Nov. 10, 2025 (Health News) — Millions of Americans who rely on medication for attention deficit hyperactivity disorder (ADHD) may be affected by a new drug recall.  Sun Pharmaceutical Industries has issued a voluntary, nationwide recall for several lots of lisdexamfetamine dimesylate capsules, a generic version of an ADHDContinue Reading

MONDAY, Nov. 3, 2025 (HealthDay News) — The U.S. Food and Drug Administration (FDA) has recalled over half a million bottles of a widely prescribed blood pressure medication, prazosin hydrochloride, because of concerns about a potentially cancer-causing chemical. New Jersey-based Teva Pharmaceuticals and drug distributor Amerisource Health Services initiated theContinue Reading